Experts Tell F.D.A. It Should Gather More Safety Data on Covid-19 Vaccines
Vaccine experts peppered officials at the Food and Drug Administration with a range of questions on Thursday about its guidelines for approving a coronavirus vaccine, pushing the agency on whether it should wait longer to collect more safety data and whether an emergency approval could jeopardize the outcome of the broader clinical trials. The stakes,…